Switch to:

Ascendis Pharma A/S Asset Impairment Charge

: $0.00 Mil (TTM As of Sep. 2019)
View and export this data going back to 2015. Start your Free Trial

Ascendis Pharma A/S's Asset Impairment Charge for the three months ended in Sep. 2019 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00 Mil.


Ascendis Pharma A/S Asset Impairment Charge Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ascendis Pharma A/S Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Asset Impairment Charge Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ascendis Pharma A/S Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Asset Impairment Charge Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ascendis Pharma A/S Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2019 was 0 (Dec. 2018 ) + 0 (Mar. 2019 ) + 0 (Jun. 2019 ) + 0 (Sep. 2019 ) = $0.00 Mil.


Ascendis Pharma A/S Asset Impairment Charge Related Terms


Ascendis Pharma A/S Asset Impairment Charge Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */